Can a double dose stop Post-Procedure pancreatitis?
NCT ID NCT07247682
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two doses of a rectal anti-inflammatory drug (indomethacin) to prevent pancreatitis after an ERCP procedure in people at high risk. About 1,036 adults will be randomly assigned to receive either 100 mg or 200 mg right after the procedure. The goal is to see if the higher dose reduces the number and severity of pancreatitis cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST ERCP PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230022, China
Contact Phone: •••-•••-•••• Email: •••••@•••••